Stay updated on Olaparib vs Chemotherapy in BRCA+ Metastatic Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Olaparib vs Chemotherapy in BRCA+ Metastatic Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Olaparib vs Chemotherapy in BRCA+ Metastatic Breast Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Study status updated to Completed with new completion/actual dates; the previous Active, not recruiting status was removed.
    Difference
    0.1%
    Check dated 2026-02-18T03:28:35.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and the government funding lapse notice was removed from the page; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-11T02:13:11.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A site-wide government funding status notice has been added and the page revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-03T22:34:29.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added a glossary display and updated metadata labels, including a new 'Last Update Submitted that Met QC Criteria' entry and revision to v3.4.0, with capitalization changes for 'No FEAR Act Data'.
    Difference
    0.1%
    Check dated 2026-01-27T21:16:26.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-20T15:31:56.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Expanded the page's Locations section to list trial sites by state (California, Colorado, Connecticut, District of Columbia, Florida, Georgia, Illinois, Kansas, Louisiana, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, New Hampshire, New York, Ohio, Oregon, Pennsylvania, Tennessee, Texas, Vermont) and added the Revision: v3.3.3 tag; removed individual state 'Locations' blocks and the HHS Vulnerability Disclosure link.
    Difference
    1.0%
    Check dated 2025-12-23T00:50:54.000Z thumbnail image

Stay in the know with updates to Olaparib vs Chemotherapy in BRCA+ Metastatic Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Olaparib vs Chemotherapy in BRCA+ Metastatic Breast Cancer Clinical Trial page.